Abstract This invention provides a matrix composition for sustained drug delivery which is comprised of an active agent, a hydrophilic polymer and an enteric polymer. The enteric polymer is impermeable to gastric fluids and aids in retarding drug release in regions of low pH, thus allowing lower levels of hydrophilic polymer to be employed. At the pH range of intestinal fluids, this polymer will dissolve and thereby increase the permeability of the dosage form. This approach is useful in sustaining the release of numerous active agents whose solubility declines as the pH is increased, a characteristic of weakly basic drugs. By responding to changes in physiological pH, these sustained release dosage forms have acceptable performance, in spite of variability in the gastrointestinal transit times of the formulation.
A sustained release matrix formulation in tablet unit dosage from comprising from about 0.1% by weight to about 90% by weight of cefaclor, from about 5% by weight to about 29% by weight of a hydrophilic polymer, and from about 0.5% by weight to about 25% by weight of an acrylic polymer which dissolves at a pH in the range of about 5.0 to about 7.4, with the proviso that the total weight of the hydrophilic polymer and said acrylic polymer is less than 30% by weight of the formulation.
Claim 2
Dependent Claim
90 words
A sustained release matrix formulation in tablet unit dosage from comprising from about 0.1% by weight to about 90% by weight of cefaclor, from about 5% by weight to about 29% by weight of a hydrophilic polymer, and from about 0.5% by weight to about 25% by weight of an acrylic polymer which dissolves at a pH in the range of about 5.0 to about 7.4, with the proviso that the total weight of the hydrophilic polymer and said acrylic polymer is less than 30% by weight of the formulation.
Claim 3
Dependent Claim
26 words
A formulation of claim 1 wherein the cefaclor is present at a concentration in the range of about 45% by weight to about 85% by weight.
Claim 4
Dependent Claim
27 words
A formulation of claim 1 wherein the hydrophilic polymer is present at a concentration in the range of about 5% by weight to about 20% by weight.
Claim 5
Dependent Claim
27 words
A formulation of claim 1 wherein the acrylic polymer is present at a concentration in the range of about 1.5% by weight to about 15% by weight.
Claim 6
Dependent Claim
43 words
The formulation of claim 1 which consists essentially of the following ingredients, in percent by weight: ______________________________________
Weight
Ingredient (Percent)
______________________________________
Cefaclor 75.80
mannitol 5.80
hydroxypropyl methylcellulose
14.93
methacrylic acid copolymer
1.09
hydroxypropyl cellulose
0.94
stearic acid powder 1.01
magnesium stearate 0.43
______________________________________